Prevision Medicine

Prevision Medicine

This company develops a live-cell testing platform that provides personalised drug response reports to help oncologists select effective treatments for cancer patients.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Pear Bio

The company develops a precision medicine platform using microfluidic chips and computer vision to predict cancer treatment efficacy for oncologists and pharmaceutical researchers.

Foundation Medicine

This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Kiyatec

This company develops 3D cell culture platforms to predict patient-specific responses to cancer therapies for oncologists and biopharmaceutical companies.

Elephas Biosciences

This company develops a live tissue platform for predicting immunotherapy response to assist oncologists, researchers, and pharmaceutical developers in cancer treatment.